Search
Biote Corp
BTMDAdd to Watchlist
2.126USD
+0.136+6.84%
Market hours （ET）Quotes delayed by 15 min
63.76MMarket Cap
4.23P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+6.86%
5 Days
+1.26%
1 Month
+0.78%
6 Months
-18.21%
Year to Date
-18.21%
1 Year
-48.39%
Key Figures
2.010Open
2.130High
38.87KVolume
4.23P/E TTM
3.78P/E Dynamic
--Dividend TTM
0.13%Turnover Ratio
1.990Prev. Close
2.007Low
57.78KTurnover
20.19P/E Static
-1.14P/B
0.00%Div Yield TTM
17.36%ROA
4.75052wk High
0.07Volume Ratio
3.16MNet Profit
29.99MShares
0.5031EPS TTM
1.68Beta
--ROE
1.27052wk Low
6.15%Amplitude
68.88%Gross Margin
63.76MMarket Cap
-1.84Reward/Risk
4.04%Risk Rate
TradingKey Stock Score of Biote Corp
Currency: USD Updated: 2026-07-01Key Insights
Biote Corp's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 83 out of 162 in the Professional & Commercial Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.99.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Biote Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Biote Corp Highlights
StrengthsRisks
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 192.22M.
Fairly Valued
The company’s latest PE is 3.96, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 20.55M shares, decreasing 10.26% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 102.70K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.22.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
2.986
Target Price
+57.99%
Upside Space
Biote Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Biote Corp Info
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Ticker SymbolBTMD
CompanyBiote Corp
CEOChristensen (Bret)
Websitehttps://haymakeracquisition.com/
Related Instruments
+4.07%
-4.50%
+2.03%
+3.25%
+3.35%
-1.60%
+0.95%
-6.49%
+1.13%
+1.87%
+2.77%
+1.95%
+2.52%
+3.40%
-8.82%
+2.80%
-3.74%
-5.24%
+4.42%
0.00%Popular Instruments
52636.400
+382.100 (+0.73%)
29288.300
-511.000 (-1.72%)
7457.200
-18.300 (-0.24%)
14749.000
-606.000 (-3.95%)
67969.000
-1516.000 (-2.18%)
6351.600
+76.200 (+1.21%)
67.984
+0.016 (+0.02%)
307.902
+13.522 (+4.59%)
193.675
-3.905 (-1.98%)
4116.520
+85.750 (+2.13%)
FAQs
What is the current price of Biote Corp (BTMD)?
The current price of Biote Corp (BTMD) is 1.99.
What is the symbol of Biote Corp?
The ticker symbol of Biote Corp is BTMD.
What is the 52-week high of Biote Corp?
The 52-week high of Biote Corp is 4.75.
What is the 52-week low of Biote Corp?
The 52-week low of Biote Corp is 1.27.
What is the market capitalization of Biote Corp?
The market capitalization of Biote Corp is 74.79M.
Is Biote Corp (BTMD) currently rated as Buy, Hold, or Sell?
According to analysts, Biote Corp (BTMD) has an overall rating of Buy, with a price target of 2.99.
What is the Earnings Per Share (EPS TTM) of Biote Corp (BTMD)?
The Earnings Per Share (EPS TTM) of Biote Corp (BTMD) is 0.86.